Skip to main content
Clinical Trials/NCT01553240
NCT01553240
Terminated
N/A

Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies

New York State Psychiatric Institute1 site in 1 country8 target enrollmentJune 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
New York State Psychiatric Institute
Enrollment
8
Locations
1
Primary Endpoint
Repetitive Behavior Scale-revised
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

This study uses functional brain imaging and noninvasive brain stimulation techniques to study the brain basis of developmental disorders like Autism Spectrum Disorder and Asperger Disorder. Functional magnetic resonance imaging (fMRI) and recently approved FDA treatment of depression, Transcranial magnetic stimulation (TMS) will be used to study the neurocircuitry of certain symptom clusters in developmental disorders.

Detailed Description

The purpose of this research is to study areas of the brain that may have something to do with repetitive movements (things that people do over and over again) and difficulty communicating with other people (problems with talking to, understanding, or just being in a relationships with other people). The investigators are trying to find out why these brain areas are working differently in people with developmental disorders, such as Autism and how the investigators can one day improve them with new brain stimulation techniques. The investigators will do screening to make sure that you are eligible for the study. After screening, the investigators will do functional MRI. In this procedure the subject or the control will be looking at videos developed to understand their social communication and language skills. The investigators will be able to understand differences of brain activation between patients and control. The investigators will also use TMS to identify the difference of motor excitability between patients and healthy control.

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
June 2010
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • for Healthy volunteer:
  • no current psychiatric disorder meeting Axis 1 DSM-4 criteria.
  • English speaking,
  • verbal and full scale IQ \> 65,
  • capacity to give consent and signed HIPPA authorization.
  • for Autism Spectrum Disorders:
  • diagnosed with Autism, Asperger or Pervasive Developmental Disorder not otherwise specified,
  • English speaking,
  • capacity to give consent and verbal and full scale IQ \> 65,
  • signed HIPPA authorization,

Exclusion Criteria

  • for Healthy control and ASD:
  • women of child bearing potential not using birth control pills or breast feeding,
  • h/o bipolar disorder (lifetime),
  • any psychotic disorder( lifetime),
  • history of major depressive disorder or of substance abuse or dependence within the past year,
  • verbal or full scale IQ less than or equal to 65,
  • intracranial implants,
  • metallic implants,
  • shrapnel in the body,
  • metallic braces,

Outcomes

Primary Outcomes

Repetitive Behavior Scale-revised

Time Frame: during screening

Secondary Outcomes

  • Vineland Maladaptive Behavior Scale(during screening)

Study Sites (1)

Loading locations...

Similar Trials